SCHEMBL990102

SCHEMBL990102

C#CCCCC(=O)CCCCCCCCC(=O)O

nearest known ligand 0.79

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.79
HSD17B10 Q99714 2/20 0.79
CYP1A2 P05177 1/20 0.79
CYP2D6 P10635 1/20 0.79
CYP2C9 P11712 1/20 0.79
CYP2C19 P33261 1/20 0.79
KMT2A Q03164 2/20 0.54
TSHR P16473 4/20 0.52
LMNA P02545 2/20 0.52
NFKB1 P19838 1/20 0.52
PMP22 Q01453 1/20 0.52
GPR84 Q9NQS5 3/20 0.44
FFAR1 O14842 1/20 0.44
FFAR4 Q5NUL3 1/20 0.44
FOLH1 Q04609 1/20 0.44
PTPN7 P35236 3/20 0.44
HMGCR P04035 1/20 0.44
PPARG P37231 3/20 0.43
PPARD Q03181 3/20 0.43
PPARA Q07869 3/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL988347 0.96 MAPT (0.87) MAPTHSD17B10CYP1A2CYP2D6CYP2C9
SCHEMBL20293445 0.89 HSD17B10 (1.00) MAPTHSD17B10CYP1A2CYP2D6CYP2C9
SCHEMBL40510 0.89 HSD17B10 (1.00) MAPTHSD17B10CYP1A2CYP2D6CYP2C9
SCHEMBL257132 0.89 HSD17B10 (1.00) MAPTHSD17B10CYP1A2CYP2D6CYP2C9
SCHEMBL2985078 0.89 HSD17B10 (1.00) MAPTHSD17B10CYP1A2CYP2D6CYP2C9
SCHEMBL1050169 0.89 HSD17B10 (1.00) MAPTHSD17B10CYP1A2CYP2D6CYP2C9
SCHEMBL12680242 0.89 HSD17B10 (1.00) MAPTHSD17B10CYP1A2CYP2D6CYP2C9
SCHEMBL2803510 0.89 HSD17B10 (1.00) MAPTHSD17B10CYP1A2CYP2D6CYP2C9
SCHEMBL740489 0.89 HSD17B10 (1.00) MAPTHSD17B10CYP1A2CYP2D6CYP2C9
SCHEMBL2802414 0.89 HSD17B10 (1.00) MAPTHSD17B10CYP1A2CYP2D6CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110020837-A1 Method for isolating or identifying a target protein interacting with a lipid in a cell UNIVERSITEIT UTRECHT HOLDING B.V. (NL) 2011-01-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110020837-A1 Method for isolating or identifying a target protein interacting with a lipid in a cell PLIN5, PLIN1, PLIN3 MAPT 4763/4885HSD17B10 442/4885CYP1A2 4328/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.